Pfizer
Search results
Zoetis is the largest global animal health company committed to nurturing the world and humankind by advancing care for animals. Learn more.
Zoetis discovers, develops, manufactures and commercializes a diverse portfolio of animal health medicines and vaccines designed to meet the real-world needs of veterinarians and the livestock farmers and companion animal owners they support.
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer , [7] the world's largest drug maker , but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.
Zoetis discovers, develops, manufactures and commercializes vaccines, medicines, diagnostics and other technologies for companion animals and livestock. A Fortune 500 company traded on the NYSE (ZTS), we generated $8.5 billion in revenue in 2023.
Zoetis | 440,941 followers on LinkedIn. Nurturing our world and humankind by advancing care for animals | The world’s leading animal health company. Zoetis is driven by a singular purpose: to...
Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways. We work every day to better understand and address the real-world challenges faced by those who raise and care for animals.
Explore all Zoetis Animal Health products for companion animal and livestock, as well as our innovative diagnostic solutions. Learn more.
Zoetis offers a unique opportunity to work in the animal health industry and one where we focus on our colleagues, customers and community every day. Take a minute to learn about the power of our purpose and see if this might be the place for you.
Turn your Zoetis product purchases into redeemable points and save money on future vet visits.
Zoetis is the world's largest animal health company, offering products and services for pets and livestock. Learn more about their mission and vision.
